Skip to content

GujjuTicks brief

Zydus Lifesciences Extends Sterling API Deal to September 2026 | Market News & Analysis

The target business adds products including Lovastatin, Daunorubicin, Doxorubicin and Epirubicin, along with a Gujarat manufacturing facility near ... This GujjuTicks brief summarizes the headline for local readers; read the full story on the publisher site.

This is a short GujjuTicks summary for discovery. Full reporting and quotes belong to the original publisher.

Read full story More in Gujarat business Today’s edition